Is Increased Corporate Fraud and Compliance Oversight on the Horizon for Healthcare Companies?

Recently, the United States Deputy Attorney General issued a Memorandum entitled “Individual Accountability for Corporate Wrongdoing” which signals intent by federal prosecutors to increasingly investigate and prosecute corporate executives’ and officers’ roles in corporate fraud and compliance issues. While not specifically targeted to the healthcare industry, this increased focus could affect the compliance culture, as the purpose is to “seek accountability from the individuals who perpetrate wrongdoing.”